{"url_path":"/fda/drug/recalls/D-0486-2026","section_key":"summary","section_title":"DRUG Recall: Leading Pharma, LLC — Furosemide Tablets, USP, 80 mg, 100 Tablets bottles, Rx only, Manufactured by: Leading Pharma, LLC, Fairfield, NJ 07004, NDC 69315-118-01","topic":"fda","document":{"doc_type":"drug-recall","doc_date":"2026-03-20","source_url":"https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0486-2026%22","accession_number":null,"cik":null,"ticker":null,"issuer_name":null,"edgar_url":null,"primary_entity_key":null,"primary_entity_name":"Leading Pharma, LLC"},"word_count":73,"has_tables":false,"body_markdown":"# FDA DRUG Recall: D-0486-2026\n\n**Recalling firm:** Leading Pharma, LLC\n**Classification:** Class II\n**Status:** Ongoing\n**Type:** Voluntary: Firm initiated\n**Initiated:** 2026-03-20\n**Report date:** 2026-04-29\n\n## Product\nFurosemide Tablets, USP, 80 mg, 100 Tablets bottles, Rx only, Manufactured by: Leading Pharma, LLC, Fairfield, NJ 07004, NDC 69315-118-01\n\n## Reason\nCGMP Deviations; presence of N-nitroso-Furosemide (NNF) above the recommended intake limit.\n\n## Affected lots\nLots# H03125, H03225, H03325, Exp Date: 2027/08\n\n## Distribution\nUS Nationwide."}